These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin. Sellin D, Yan LM, Kapurniotu A, Winter R. Biophys Chem; 2010 Aug 27; 150(1-3):73-9. PubMed ID: 20153100 [Abstract] [Full Text] [Related]
16. Islet amyloid polypeptide: identification of long-range contacts and local order on the fibrillogenesis pathway. Padrick SB, Miranker AD. J Mol Biol; 2001 May 11; 308(4):783-94. PubMed ID: 11350174 [Abstract] [Full Text] [Related]
17. The cytoplasmic domains of phospholamban and phospholemman associate with phospholipid membrane surfaces. Clayton JC, Hughes E, Middleton DA. Biochemistry; 2005 Dec 27; 44(51):17016-26. PubMed ID: 16363815 [Abstract] [Full Text] [Related]
18. Effect of lipid type on the binding of lipid vesicles to islet amyloid polypeptide amyloid fibrils. Sasahara K, Hall D, Hamada D. Biochemistry; 2010 Apr 13; 49(14):3040-8. PubMed ID: 20210361 [Abstract] [Full Text] [Related]
19. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide. Kapurniotu A. Biopolymers; 2001 Apr 13; 60(6):438-59. PubMed ID: 12209476 [Abstract] [Full Text] [Related]